A genetic model of vesicoureteral reflux and reflux nephropathy
A genetic model of vesicoureteral reflux and reflux nephropathy
批准号:
8286408
负责人:
CARLTON MATTHEW BATES
金额:
$33.27万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-15 至 2013-03-31
关键词:
AdultBladderChildChronic Kidney FailureCicatrixCongenital AbnormalityEvaluationFibroblast Growth Factor Receptor 2Functional disorderGeneticGenetic ModelsGenitourinary systemGoalsIncidenceInjuryKidneyKidney DiseasesKidney FailureMediatingMesenchymeMetanephric DiverticulumMolecularMusMutant Strains MiceMyofibroblastNatural HistoryPathway interactionsRefluxRoleSignal TransductionSiteSterilityTestingTransforming Growth Factor betaUreterUrinary tractUrinary tract infectionUrineVesico-Ureteral RefluxWorkmouse modelnovelnovel therapeuticspublic health relevancetherapeutic targettreatment strategy
中文摘要
描述(由申请人提供):膀胱输尿管反流(VUR-尿液从膀胱回流到输尿管)是儿童最常见的泌尿生殖系统异常,反流肾病是儿童慢性肾衰竭的第四大原因。该应用的长期目标是了解儿童膀胱输尿管反流和反流肾病的病理生理学,最终提供最合适的治疗策略。为此,已经产生了一种小鼠系,这是一种新的膀胱输尿管反流遗传模型。命名为fgfr2Mes-/-的小鼠(由于肾后肾间充质纤维母细胞生长因子受体2的条件性缺失),输尿管芽诱导部位经常出现异常,这可能导致幼龄产后小鼠VUR的高发。许多患有持续性VUR的成年fgfr2Mes-/-小鼠(但没有明显的尿路感染)有疤痕,与反流肾病一致。这些小鼠有肌成纤维细胞转化的证据,与转化生长因子(TGF-2)介导的损伤一致。我们的工作假设是fgfr2Mes-/-小鼠代表了膀胱输尿管反流和无菌反流肾病的独特遗传模型,TGF-2信号是介导反流肾病肾损伤的关键分子途径。为了验证这一假设,产生了以下目标:具体目标1:阐明为什么fgfr2Mes-/-小鼠容易发生VUR,检查输尿管、膀胱和输尿管-膀胱(输尿管囊)连接处的形成。特异性目的2:完全描述fgfr2Mes-/-小鼠VUR和反流肾病的自然历史。特异性目的3:阐明异常TGF-2信号在反流性肾病进展中的作用,包括其作为治疗靶点的效用。这种独特的小鼠模型将允许仔细评估膀胱输尿管反流和反流肾病的病理生理学,这应该为患有这些疾病的儿童提供新的治疗策略。
英文摘要
DESCRIPTION (provided by applicant): Vesicoureteral reflux (VUR- backflow of urine from the bladder into the ureter) is the most common urogenital anomaly in children and reflux nephropathy is the 4th leading cause of chronic renal failure in children. The application's broad long-term objectives are to understand the pathophysiology of vesicoureteral reflux and reflux nephropathy in children to ultimately offer the most appropriate treatment strategies. To that end, a mouse line has been generated that is a novel genetic model of vesicoureteral reflux. The mice, designated fgfr2Mes-/- (due to conditional deletion of fibroblast growth factor receptor 2 from kidney metanephric mesenchyme), frequently have abnormalities in ureteric bud induction site(s), which likely leads to the high incidence of VUR in young post natal mice. Many adult fgfr2Mes-/- mice with persistent VUR (but no obvious urinary tract infections) have scarring, consistent with reflux nephropathy. These same mice have evidence of myofibroblast transformation consistent with transforming growth factor beta (TGF-2) mediated injury. It is our working hypothesis that the fgfr2Mes-/- mice represent a unique genetic model of vesicoureteral reflux and sterile reflux nephropathy, and that TGF-2 signaling is a key molecular pathway mediating renal injury in reflux nephropathy. To test this hypothesis, the following aims have been generated: Specific Aim 1: Elucidate why the fgfr2Mes-/- mice are prone to VUR, examining formation of the ureter, bladder and ureter-bladder (ureterovesicle) junction. Specific Aim 2: Completely characterize the natural history of VUR and reflux nephropathy in fgfr2Mes-/- mice. Specific Aim 3: Elucidate the role of aberrant TGF-2 signaling in the progression of reflux nephropathy, including its utility as a therapeutic target. This unique mouse model will permit careful evaluation of the pathophysiology of vesicoureteral reflux and reflux nephropathy, which should provide novel therapeutic strategies for children with these conditions.
PUBLIC HEALTH RELEVANCE:
Vesicoureteral reflux (backflow of urine from the bladder into the ureter toward the kidney) is the most common urinary tract birth defect. This often leads to reflux nephropathy, a leading cause of kidney failure in children. We have a mouse mutant that develops reflux and subsequent reflux nephropathy. This mouse model will help us determine how best to treat children with this condition.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0056062
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Walker KA, Sims-Lucas S, Di Giovanni VE, Schaefer C, Sunseri WM, Novitskaya T, de Caestecker MP, Chen F, Bates CM]
通讯作者:
Bates CM
DOI:
10.1007/s00467-010-1747-z
发表时间:
2011-09
期刊:
PEDIATRIC NEPHROLOGY
影响因子:
3
作者:
[Bates, Carlton M.]
通讯作者:
Bates, Carlton M.
The University of Pittsburgh Summer Research Internship Program kidney workshop (SRIP-Kid)
-
批准号:10088062
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2021
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Role of Fgfr2 signaling in bladder injury and regeneration
-
批准号:9978050
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2019
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Role of Fgfr2 signaling in bladder injury and regeneration
-
批准号:10187557
-
项目类别:
-
资助金额:$22.93万
-
财政年份:2019
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Critical Roles for Fibroblast Growth Factor Receptors in Bladder Development
-
批准号:8985305
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2015
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
The 13th International Workshop on Developmental Nephrology: From Basic Models to Translational Science
-
批准号:8908658
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Role of Receptors in the Metanephric Mesenchyme
-
批准号:8640940
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2013
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
12th International Workshop on Developmental Nephrology
-
批准号:8517912
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2013
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Role of Receptors in the Metanephric Mesenchyme
-
批准号:8496985
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2013
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8513986
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:9070063
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8290565
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8703086
-
项目类别:
-
资助金额:$13.91万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8073764
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:9306830
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8420537
-
项目类别:
-
资助金额:$29.22万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8265965
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:7770174
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8037048
-
项目类别:
-
资助金额:$30.25万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8618897
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
A genetic model of vesicoureteral reflux and reflux nephropathy
-
批准号:7577263
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2009
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
海外基金